Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring
Completed
- Conditions
- Congestive Heart Failure
- Registration Number
- NCT04362553
- Lead Sponsor
- Northwestern University
- Brief Summary
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent agreement with pilot sensor and current standard of vital signs monitoring 2 years Percent agreement with pilot sensor and current standard of vital signs monitoring
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie hemodynamic monitoring in congestive heart failure using wearable sensors?
How does the wearable vital signs sensor compare to standard-of-care monitoring in predicting decompensation events in CHF patients?
Which biomarkers are most predictive of response to continuous hemodynamic monitoring in advanced heart failure?
What adverse events are associated with long-term use of wireless wearable sensors in heart failure management?
Are there combination approaches integrating wearable sensors with current drug therapies like beta-blockers or ARBs for optimizing CHF outcomes?
Trial Locations
- Locations (1)
Northwestern Memorial Hospital
🇺🇸Chicago, Illinois, United States
Northwestern Memorial Hospital🇺🇸Chicago, Illinois, United States